Invest 1 B.V. ALS

AMLX

Invest 1 B.V. ALS serves as 10% Owner at Amylyx Pharmaceuticals, Inc. (AMLX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$1.25M

Net Position

Net Seller

$1.25M

Companies Traded

AMLX

Active Period

Jul 2022

1 total trades

Most Recent

Sell AMLX

Jul 6, 2022 · $1.25M

Invest 1 B.V. ALS's Insider Trading at Amylyx Pharmaceuticals, Inc. (AMLX)

Buys

0 · $0.00

Sells

1 · $1.25M

Total Shares Bought

Total Shares Sold

60,609

AMLX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 6, 2022	Sell	60,609	$20.70	$1.25M	0

Related Insiders

Karen Firestone

Director

AMLXBuy · May 26, 2026

Gina Mazzariello

officer: Chief Legal Officer

AMLXSell · Feb 25, 2026

Joshua B Cohen

director, officer: Co-Chief Executive Officer

AMLXSell · Feb 4, 2026

FRATES JAMES M

officer: Chief Financial Officer

AMLXSell · Feb 4, 2026

Justin B. Klee

director, officer: Co-Chief Executive Officer

AMLXSell · Feb 4, 2026

Camille L Bedrosian

Chief Medical Officer

AMLXSell · Dec 1, 2025

Explore More Insider Trading Data

AMLX Insider Trading Activity

View all insider trades at Amylyx Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity